Fundraising Fox

Norwich Ventures

Venture capital

Waltham · Seed–Series A · 4 people tracked

Also known as NORWICH VENTURES MANAGEMENT, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Norwich Ventures specializes in early-stage medtech investing, providing initial capital in seed and early-stage rounds to entrepreneurs developing game-changing medical technologies that solve large unmet medical needs. The firm looks for passionate founders, large unmet needs, best-in-class technology, capital efficiency, barriers to entry, and a quick path to proof of concept. It takes a long-term perspective and is agnostic about the field of medicine, having supported companies across electrophysiology, genomics, women's health and more.

Source: firm website, verified Aug 25, 2026.

Stage
Seed–Series A
HQ
Waltham, Massachusetts, US
Instruments
Equity
Founded
2004
Private fund assets
$26.6M
VC funds
1
Tracked investments
13

Team · 4 people

from the firm's website & public directories
Marlin Miller· Co-Founder and Senior Advisor
Phil Fleck· Advisor (In Memoriam)

Listed on the page as in memoriam.

What they invest in

from 8 of 13 portfolio companies

Medical Devices ×6Biotech ×5Healthtech ×5Advanced Manufacturing ×2Deep Tech ×1Digital Health ×1FemTech ×1

HQs:United States×5Japan×1

Investments · 13 tracked

founders shown can be your intro path

By year:2025 · 22021 · 12015 · 14 dated

Boston ScientificNYSE: BSX
MedtronicNYSE: MDT
Lexington Medical, Inclexington-med.cominApr 2025✓ verified

Lexington Medical is a surgical stapling company that develops endostapler devices for surgical procedures, including its AEON Endostapler used in thoracic surgery such as lung volume reduction.

Advanced ManufacturingHealthtechMedical DevicesBedford, US

Leon Amariglio(Founder & CEO)Jameson Kief(Director of Engineering)Marc Jin(Chief Operating Officer)Yuval Somekh(Chief Financial Officer)Andrew Marecki(EVP of Technology)

BoardDavid Roberts(Director)

Board seatAaron Sandoski· per SEC Form D

Co-investorsAmpersand

Daktari Diagnosticsdaktaridx.comMar 2015SEC filingmedium confidence

BiotechCambridge, US

Donald Hawthorne(Executive Officer, Director)Christopher Earl(Director)Stanley Lapidus(Director)Roger Kitterman(Director)William Rodriguez(Executive Officer, Director)Edward Roberts(Director)

Board seatAaron Sandoski· per SEC Form D · $22.5M raise · filed May 2016

Co-investorsBoston Harbor Angels

Nanopathnanopath.comin𝕏Jan 2025SEC filingmedium confidence

Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health.

BiotechFemTechMedical DevicesCambridge, US

Alison Burklund(Executive Officer, Director)inAmogha Tadimety(Executive Officer, Director)in

BoardJeff Crowe(Director)

Board seatAaron Sandoski· per SEC Form D · $6M raise · filed Feb 2025

Co-investorsNorwest Venture PartnersService Provider CapitalGingerbread CapitalMedtech Convergence

Podimetricspodimetrics.cominDec 2021

Podimetrics offers a remote monitoring and care program for people with complex diabetes, centered on the SmartMat device that collects foot-health data to enable early intervention and prevent complications such as amputations.

Digital HealthHealthtechMedical DevicesSomerville, US

David Linders(Executive Officer, Director)Jonathan Bloom(Executive Officer, Director)

Board seatAaron Sandoski· per SEC Form D

Co-investorsScientific Health DevelopmentSV Health InvestorsPolaris PartnersRock Health

IONpathionpath.com

IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery.

BiotechDeep TechMedical Devices

Co-investorsVertical Venture Partners

Laborie
Qiagen
ReThink Medicalrethinkmedical.com

HealthtechSan Francisco, US

Reza Naima(Executive Officer, Director)

Co-investorsEmergent Medical Partners, LLPLaunchCapitalEmergent Medical PartnersLaunch Capital

Tempus
Terumoterumomedical.comin

Terumo Medical Corporation manufactures medical devices and healthcare products across four divisions, including interventional systems for vascular access, injection and infusion devices, drug delivery devices, and precision medicine software and care pathway consulting.

Advanced ManufacturingBiotechHealthtechMedical DevicesTokyo, JP

vacessvaxess.com

Terrestrial develops the Tacterra microarray patch platform, a dissolvable skin-patch technology for delivering therapies including GLP-1 without injection.

BiotechHealthtechMedical Devices

Rachel Sha(CEO)

Co-investorsMission BiocapitalUlu VenturesThe Engine Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 2

IPOs and acquisitions across the tracked portfolio

Boston ScientificNYSE: BSXMedtronicNYSE: MDT

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Norwich Ventures made?
Norwich Ventures has 10 tracked investments, including 1 dated in the last 24 months.
What stage does Norwich Ventures invest at?
Norwich Ventures invests at the Seed, Series A stages.
What sectors does Norwich Ventures focus on?
Norwich Ventures focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices.
Where is Norwich Ventures located?
Norwich Ventures is headquartered in Waltham, US.
Who does Norwich Ventures co-invest with?
Norwich Ventures most often shares deals with Mission Biocapital, Scientific Health Development, SV Health Investors, among 6 tracked co-investors.

Media · Podcasts & interviews

featuring the team

BlankCheck - Aaron Sandoski, Managing Director | Norwich Ventures

pioneerrwjf · Aaron Sandoski

Similar investors

Future Positive Capital

Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.

MedMountain Ventures

MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.

$500K – $5M
Sv Tech Ventures, Inc.

SV Tech Ventures is a Palo Alto-based venture capital firm investing in early-stage, high-tech startups, offering hands-on support with strategy, product, fundraising, and hiring across its funds.

Overwater Ventures Llc

Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.

$400K – $2M
Wavemaker Three-Sixty Health

Wavemaker 360 is a healthcare-focused venture capital firm that backs entrepreneurs building disruptive companies transforming the healthcare industry. Its limited partners are largely individuals with significant healthcare industry experience.

$500K – $2M

Featured in lists